416 related articles for article (PubMed ID: 25740596)
1. N-Acetyl-Seryl-Aspartyl-Lysyl-Proline: mechanisms of renal protection in mouse model of systemic lupus erythematosus.
Liao TD; Nakagawa P; Janic B; D'Ambrosio M; Worou ME; Peterson EL; Rhaleb NE; Yang XP; Carretero OA
Am J Physiol Renal Physiol; 2015 May; 308(10):F1146-54. PubMed ID: 25740596
[TBL] [Abstract][Full Text] [Related]
2. Effects of N-acetyl-seryl-asparyl-lysyl-proline on blood pressure, renal damage, and mortality in systemic lupus erythematosus.
Nakagawa P; Masjoan-Juncos JX; Basha H; Janic B; Worou ME; Liao TD; Romero CA; Peterson EL; Carretero OA
Physiol Rep; 2017 Jan; 5(2):. PubMed ID: 28126732
[TBL] [Abstract][Full Text] [Related]
3. Treatment with N-acetyl-seryl-aspartyl-lysyl-proline prevents experimental autoimmune myocarditis in rats.
Nakagawa P; Liu Y; Liao TD; Chen X; González GE; Bobbitt KR; Smolarek D; Peterson EL; Kedl R; Yang XP; Rhaleb NE; Carretero OA
Am J Physiol Heart Circ Physiol; 2012 Nov; 303(9):H1114-27. PubMed ID: 22923621
[TBL] [Abstract][Full Text] [Related]
4. Ac-SDKP ameliorates the progression of lupus nephritis in MRL/lpr mice.
Tan H; Zhao J; Wang S; Zhang L; Wang H; Huang B; Liang Y; Yu X; Yang N
Int Immunopharmacol; 2012 Dec; 14(4):401-9. PubMed ID: 22922317
[TBL] [Abstract][Full Text] [Related]
5. N-acetyl-seryl-aspartyl-lysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephritis.
Omata M; Taniguchi H; Koya D; Kanasaki K; Sho R; Kato Y; Kojima R; Haneda M; Inomata N
J Am Soc Nephrol; 2006 Mar; 17(3):674-85. PubMed ID: 16452498
[TBL] [Abstract][Full Text] [Related]
6. Renal protective effect of N-acetyl-seryl-aspartyl-lysyl-proline in dahl salt-sensitive rats.
Worou ME; Liao TD; D'Ambrosio M; Nakagawa P; Janic B; Peterson EL; Rhaleb NE; Carretero OA
Hypertension; 2015 Oct; 66(4):816-22. PubMed ID: 26324505
[TBL] [Abstract][Full Text] [Related]
7. N-acetyl-seryl-aspartyl-lysyl-proline attenuates renal injury and dysfunction in hypertensive rats with reduced renal mass: council for high blood pressure research.
Liao TD; Yang XP; D'Ambrosio M; Zhang Y; Rhaleb NE; Carretero OA
Hypertension; 2010 Feb; 55(2):459-67. PubMed ID: 20026760
[TBL] [Abstract][Full Text] [Related]
8. N-acetyl-seryl-aspartyl-lysyl-proline attenuates renal inflammation and tubulointerstitial fibrosis in rats.
Wang M; Liu R; Jia X; Mu S; Xie R
Int J Mol Med; 2010 Dec; 26(6):795-801. PubMed ID: 21042772
[TBL] [Abstract][Full Text] [Related]
9. Prevention of aortic fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in angiotensin II-induced hypertension.
Lin CX; Rhaleb NE; Yang XP; Liao TD; D'Ambrosio MA; Carretero OA
Am J Physiol Heart Circ Physiol; 2008 Sep; 295(3):H1253-H1261. PubMed ID: 18641275
[TBL] [Abstract][Full Text] [Related]
10. Renal antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats.
Castoldi G; di Gioia CR; Bombardi C; Preziuso C; Leopizzi M; Maestroni S; Corradi B; Zerbini G; Stella A
Am J Nephrol; 2013; 37(1):65-73. PubMed ID: 23327833
[TBL] [Abstract][Full Text] [Related]
11. Antifibrotic effects of N-acetyl-seryl-aspartyl-Lysyl-proline on the heart and kidney in aldosterone-salt hypertensive rats.
Peng H; Carretero OA; Raij L; Yang F; Kapke A; Rhaleb NE
Hypertension; 2001 Feb; 37(2 Pt 2):794-800. PubMed ID: 11230375
[TBL] [Abstract][Full Text] [Related]
12. Ac-SDKP suppresses TNF-α-induced ICAM-1 expression in endothelial cells via inhibition of IκB kinase and NF-κB activation.
Zhu L; Yang XP; Janic B; Rhaleb NE; Harding P; Nakagawa P; Peterson EL; Carretero OA
Am J Physiol Heart Circ Physiol; 2016 May; 310(9):H1176-83. PubMed ID: 26945075
[TBL] [Abstract][Full Text] [Related]
13. N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin.
Liu YH; D'Ambrosio M; Liao TD; Peng H; Rhaleb NE; Sharma U; André S; Gabius HJ; Carretero OA
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H404-12. PubMed ID: 19098114
[TBL] [Abstract][Full Text] [Related]
14. (5R)-5-hydroxytriptolide ameliorates lupus nephritis in MRL/
Zhang LY; Li H; Wu YW; Cheng L; Yan YX; Yang XQ; Zhu FH; He SJ; Tang W; Zuo JP
Am J Physiol Renal Physiol; 2017 Apr; 312(4):F769-F777. PubMed ID: 28100505
[TBL] [Abstract][Full Text] [Related]
15. Renal Protective Effects of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline (Ac-SDKP) in Obese Rats on a High-Salt Diet.
Maheshwari M; Romero CA; Monu SR; Kumar N; Liao TD; Peterson EL; Carretero OA
Am J Hypertens; 2018 Jul; 31(8):902-909. PubMed ID: 29722788
[TBL] [Abstract][Full Text] [Related]
16. New anti-fibrotic mechanisms of n-acetyl-seryl-aspartyl-lysyl-proline in silicon dioxide-induced silicosis.
Sun Y; Yang F; Yan J; Li Q; Wei Z; Feng H; Wang R; Zhang L; Zhang X
Life Sci; 2010 Aug; 87(7-8):232-9. PubMed ID: 20624403
[TBL] [Abstract][Full Text] [Related]
17. N-acetyl-seryl-aspartyl-lysyl-proline mediates the anti-fibrotic properties of captopril in unilateral ureteric obstructed BALB/C mice.
Chan GCW; Wu HJ; Chan KW; Yiu WH; Zou A; Huang XR; Lan HY; Lai KN; Tang SCW
Nephrology (Carlton); 2018 Apr; 23(4):297-307. PubMed ID: 28075040
[TBL] [Abstract][Full Text] [Related]
18. N-acetyl-seryl-aspartyl-lysyl-proline prevents renal insufficiency and mesangial matrix expansion in diabetic db/db mice.
Shibuya K; Kanasaki K; Isono M; Sato H; Omata M; Sugimoto T; Araki S; Isshiki K; Kashiwagi A; Haneda M; Koya D
Diabetes; 2005 Mar; 54(3):838-45. PubMed ID: 15734863
[TBL] [Abstract][Full Text] [Related]
19. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
[TBL] [Abstract][Full Text] [Related]
20. Long-term effect of N-acetyl-seryl-aspartyl-lysyl-proline on left ventricular collagen deposition in rats with 2-kidney, 1-clip hypertension.
Rhaleb NE; Peng H; Yang XP; Liu YH; Mehta D; Ezan E; Carretero OA
Circulation; 2001 Jun; 103(25):3136-41. PubMed ID: 11425781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
